Intratumoral injection of BCG-CWS-pretreated dendritic cells following tumor cryoablation

Naoshi Kawamura; Masaru Udagawa; Tomonobu Fujita; Toshiharu Sakurai; Tomonori Yaguchi; Yutaka Kawakami

doi:10.1007/978-1-4939-0345-0_13

Intratumoral injection of BCG-CWS-pretreated dendritic cells following tumor cryoablation

Naoshi Kawamura
, Masaru Udagawa
, Tomonobu Fujita
, Toshiharu Sakurai
, Tomonori Yaguchi
, Yutaka Kawakami

先端医科学研究所(細胞)

研究成果: Article › 査読

3 被引用数 (Scopus)

抄録

Intratumoral administration of dendritic cells (DC) following cryoablation of tumor is one of the personalized cancer immunotherapies which is able to induce immune responses to multiple endogenous tumor antigens, including shared and unique antigens. Here we describe protocols of cryoablation of tumors, generation of cultured DC, pretreatment of DC with a Toll-like receptor (TLR)-stimulating purified component of Bacillus Calmette-Guerin cell wall fraction (BCG-CWS) and highly immunogenic keyhole limpet hemocyanin (KLH) antigen, and combined use of tumor cryoablation and intratumoral administration of BCG-CWS-pretreated DC in both a murine model and cancer patients.

本文言語	English
ページ（範囲）	145-153
ページ数	9
ジャーナル	Methods in Molecular Biology
巻	1139
DOI	https://doi.org/10.1007/978-1-4939-0345-0_13
出版ステータス	Published - 2014

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

SDG 3 すべての人に健康と福祉を

ASJC Scopus subject areas

分子生物学
遺伝学

文献へのアクセス

10.1007/978-1-4939-0345-0_13

他のファイルとリンク

引用スタイル

@article{caac8cfa31bf4b2980d80ffc2f37f459,

title = "Intratumoral injection of BCG-CWS-pretreated dendritic cells following tumor cryoablation",

abstract = "Intratumoral administration of dendritic cells (DC) following cryoablation of tumor is one of the personalized cancer immunotherapies which is able to induce immune responses to multiple endogenous tumor antigens, including shared and unique antigens. Here we describe protocols of cryoablation of tumors, generation of cultured DC, pretreatment of DC with a Toll-like receptor (TLR)-stimulating purified component of Bacillus Calmette-Guerin cell wall fraction (BCG-CWS) and highly immunogenic keyhole limpet hemocyanin (KLH) antigen, and combined use of tumor cryoablation and intratumoral administration of BCG-CWS-pretreated DC in both a murine model and cancer patients.",

keywords = "BCG-CWS, Cryoablation, Dendritic cells, Immunotherapy, KLH",

author = "Naoshi Kawamura and Masaru Udagawa and Tomonobu Fujita and Toshiharu Sakurai and Tomonori Yaguchi and Yutaka Kawakami",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2014.",

year = "2014",

doi = "10.1007/978-1-4939-0345-0\_13",

language = "English",

volume = "1139",

pages = "145--153",

journal = "Methods in Molecular Biology",

issn = "1064-3745",

publisher = "Humana Press Inc.",

}

TY - JOUR

T1 - Intratumoral injection of BCG-CWS-pretreated dendritic cells following tumor cryoablation

AU - Kawamura, Naoshi

AU - Udagawa, Masaru

AU - Fujita, Tomonobu

AU - Sakurai, Toshiharu

AU - Yaguchi, Tomonori

AU - Kawakami, Yutaka

N1 - Publisher Copyright: © Springer Science+Business Media New York 2014.

PY - 2014

Y1 - 2014

N2 - Intratumoral administration of dendritic cells (DC) following cryoablation of tumor is one of the personalized cancer immunotherapies which is able to induce immune responses to multiple endogenous tumor antigens, including shared and unique antigens. Here we describe protocols of cryoablation of tumors, generation of cultured DC, pretreatment of DC with a Toll-like receptor (TLR)-stimulating purified component of Bacillus Calmette-Guerin cell wall fraction (BCG-CWS) and highly immunogenic keyhole limpet hemocyanin (KLH) antigen, and combined use of tumor cryoablation and intratumoral administration of BCG-CWS-pretreated DC in both a murine model and cancer patients.

AB - Intratumoral administration of dendritic cells (DC) following cryoablation of tumor is one of the personalized cancer immunotherapies which is able to induce immune responses to multiple endogenous tumor antigens, including shared and unique antigens. Here we describe protocols of cryoablation of tumors, generation of cultured DC, pretreatment of DC with a Toll-like receptor (TLR)-stimulating purified component of Bacillus Calmette-Guerin cell wall fraction (BCG-CWS) and highly immunogenic keyhole limpet hemocyanin (KLH) antigen, and combined use of tumor cryoablation and intratumoral administration of BCG-CWS-pretreated DC in both a murine model and cancer patients.

KW - BCG-CWS

KW - Cryoablation

KW - Dendritic cells

KW - Immunotherapy

KW - KLH

UR - https://www.scopus.com/pages/publications/84909636878

UR - https://www.scopus.com/pages/publications/84909636878#tab=citedBy

U2 - 10.1007/978-1-4939-0345-0_13

DO - 10.1007/978-1-4939-0345-0_13

M3 - Article

C2 - 24619677

AN - SCOPUS:84909636878

SN - 1064-3745

VL - 1139

SP - 145

EP - 153

JO - Methods in Molecular Biology

JF - Methods in Molecular Biology

ER -

Intratumoral injection of BCG-CWS-pretreated dendritic cells following tumor cryoablation

抄録

UN SDG

ASJC Scopus subject areas

文献へのアクセス

他のファイルとリンク

フィンガープリント

引用スタイル